Liquidia Corporation Alternatives & Competitors
12 companies similar to Liquidia Corporation — A biopharmaceutical company developing innovative therapies for patients with ra...
Companies similar to Liquidia Corporation
Gossamer Bio
Vision * Connection * Innovation
San Diego, United States
Chance Pharmaceuticals 畅溪制药
A clinical-stage biotech company focusing on discovering, developing and commercializing i...
China
Keros Therapeutics
Keros is dedicated to the discovery and development of novel therapeutics for multiple dis...
Lexington, United States
MannKind Corporation
Our mission is to give people control of their health and the freedom to live life.
Danbury, United States
Rival Readout
Competing with Liquidia Corporation? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Respira Therapeutics, Inc.
Improving patient outcomes through enhanced drug targeting to the lung
Palo Alto, United States
AC Immune
Shifting the treatment paradigm for neurodegenerative disease towards precision medicine a...
Lausanne, Switzerland
Oyster Point Pharma
Commercial-stage biopharmaceutical company focused on pharmaceutical therapies to treat op...
Princeton, United States
CymaBay Therapeutics
Dedicated to improving the lives of patients with liver diseases
Newark, United States
Zevra Therapeutics
A Rare Approach to Therapeutics
Celebration, United State...
Vivacitas Oncology Inc.
A clinical-stage biopharmaceutical company focused on next generation treatment options fo...
Walnut Creek, United Stat...
Innolake Biopharm
A clinical stage biotech company, aiming to provide innovative therapeutics in oncology an...
Shanghai, China
About Liquidia Corporation
Liquidia Corporation, a late-stage clinical biopharmaceutical company founded in 2004, focuses on the development and commercialization of novel products, particularly in the biopharma, biotechnology, and healthcare industries. The company's flagship product, YUTREPIA™ (treprostinil) inhalation powder, targets the trea...
Biopharmaceutical Company, Clinical Stage, Pulmonary Hypertension, PRINT® Technology, YUTREPIA™, Treprostinil, Pulmonary Arterial Hypertension, Interstitial Lung Disease, L606, Liposomal Formulation, Nebulizer, Liquidia PAH, Pharmaceutical Products, Generic Treprostinil Injection
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Liquidia Corporation: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Liquidia Corporation on 12 Sep 2024. The 11 companies listed here were last checked between 11 Sep 2024 and 18 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
